IBDEI2LU ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,498,0)
 ;;=LENS/CATARACT^6^44
 ;;^UTILITY(U,$J,358.4,499,0)
 ;;=LOW VISION/BLINDNESS^7^44
 ;;^UTILITY(U,$J,358.4,500,0)
 ;;=DIABETES^3^44
 ;;^UTILITY(U,$J,358.4,501,0)
 ;;=MOST COMMON & POST OP^1^44
 ;;^UTILITY(U,$J,358.4,502,0)
 ;;=NEUROLOGIC EYE DISEASE^8^44
 ;;^UTILITY(U,$J,358.4,503,0)
 ;;=ORBIT/EYELID/LACRIMAL^9^44
 ;;^UTILITY(U,$J,358.4,504,0)
 ;;=REFRACTION^10^44
 ;;^UTILITY(U,$J,358.4,505,0)
 ;;=RETINA/VITREOUS^11^44
 ;;^UTILITY(U,$J,358.4,506,0)
 ;;=STRABISMUS^12^44
 ;;^UTILITY(U,$J,358.4,507,0)
 ;;=SYSTEMIC/TRAUMA/OTHER^13^44
 ;;^UTILITY(U,$J,358.4,508,0)
 ;;=NEW PATIENT^2^45
 ;;^UTILITY(U,$J,358.4,509,0)
 ;;=ESTABLISHED PATIENT^1^45
 ;;^UTILITY(U,$J,358.4,510,0)
 ;;=CONSULTATIONS^3^45
 ;;^UTILITY(U,$J,358.4,511,0)
 ;;=COMPREHENSIVE ASSESSMENT/TREATMENT^2^46
 ;;^UTILITY(U,$J,358.4,512,0)
 ;;=VACCINE ADMINISTRATION^6^46
 ;;^UTILITY(U,$J,358.4,513,0)
 ;;=INJECTION ADMINISTRATION^3^46
 ;;^UTILITY(U,$J,358.4,514,0)
 ;;=INJECTIONS-DRUGS/MEDICATIONS^4^46
 ;;^UTILITY(U,$J,358.4,515,0)
 ;;=VACCINES^7^46
 ;;^UTILITY(U,$J,358.4,516,0)
 ;;=ADVANCE CARE PLANNING^1^46
 ;;^UTILITY(U,$J,358.4,517,0)
 ;;=PROLONGED SERVICES^5^46
 ;;^UTILITY(U,$J,358.4,518,0)
 ;;=DEMENTIA/COGNITIVE^6^47
 ;;^UTILITY(U,$J,358.4,519,0)
 ;;=MENTAL HEALTH^18^47
 ;;^UTILITY(U,$J,358.4,520,0)
 ;;=ABDOMINAL/GASTRO/DIGESTIVE^1^47
 ;;^UTILITY(U,$J,358.4,521,0)
 ;;=ANEMIA/BLOOD^2^47
 ;;^UTILITY(U,$J,358.4,522,0)
 ;;=BREAST/SKIN/HAIR/NAIL/SOFT TISSUE^3^47
 ;;^UTILITY(U,$J,358.4,523,0)
 ;;=CANCER^4^47
 ;;^UTILITY(U,$J,358.4,524,0)
 ;;=CARDIO/VASCULAR^5^47
 ;;^UTILITY(U,$J,358.4,525,0)
 ;;=EAR/HEARING^7^47
 ;;^UTILITY(U,$J,358.4,526,0)
 ;;=EAR/HEARING-VESTIBULAR FUNCTION^8^47
 ;;^UTILITY(U,$J,358.4,527,0)
 ;;=ENDOCRINE/METABOLIC/NUTRITIONAL^9^47
 ;;^UTILITY(U,$J,358.4,528,0)
 ;;=EYE/VISION DISORDERS^10^47
 ;;^UTILITY(U,$J,358.4,529,0)
 ;;=FALLS-INITIAL^11^47
 ;;^UTILITY(U,$J,358.4,530,0)
 ;;=GENITOURINARY^15^47
 ;;^UTILITY(U,$J,358.4,531,0)
 ;;=INFECTION^16^47
 ;;^UTILITY(U,$J,358.4,532,0)
 ;;=KIDNEY/RENAL^17^47
 ;;^UTILITY(U,$J,358.4,533,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^19^47
 ;;^UTILITY(U,$J,358.4,534,0)
 ;;=NEUROLOGICAL/CEREBROVASCULAR^20^47
 ;;^UTILITY(U,$J,358.4,535,0)
 ;;=PAIN^21^47
 ;;^UTILITY(U,$J,358.4,536,0)
 ;;=PULMONARY/RESPIRATORY^22^47
 ;;^UTILITY(U,$J,358.4,537,0)
 ;;=SLEEP DISORDERS^23^47
 ;;^UTILITY(U,$J,358.4,538,0)
 ;;=SYMPTOMS/OTHER CONDITIONS^24^47
 ;;^UTILITY(U,$J,358.4,539,0)
 ;;=FALLS-SEQUELA^12^47
 ;;^UTILITY(U,$J,358.4,540,0)
 ;;=FALLS-SUBSEQUENT^13^47
 ;;^UTILITY(U,$J,358.4,541,0)
 ;;=FUNCTION/GAIT/MOBILITY^14^47
 ;;^UTILITY(U,$J,358.4,542,0)
 ;;=NEW PATIENT^2^48
 ;;^UTILITY(U,$J,358.4,543,0)
 ;;=ESTABLISHED PATIENT^1^48
 ;;^UTILITY(U,$J,358.4,544,0)
 ;;=CONSULTATIONS^3^48
 ;;^UTILITY(U,$J,358.4,545,0)
 ;;=POST-OP FOLLOW-UP^4^48
 ;;^UTILITY(U,$J,358.4,546,0)
 ;;=ESOPHAGUS^4^49
 ;;^UTILITY(U,$J,358.4,547,0)
 ;;=SMALL INTESTINE ENDOSCOPY^11^49
 ;;^UTILITY(U,$J,358.4,548,0)
 ;;=SIGMOIDOSCOPY/PROCTOSIGMOIDOSCOPY^10^49
 ;;^UTILITY(U,$J,358.4,549,0)
 ;;=COLONOSCOPY^1^49
 ;;^UTILITY(U,$J,358.4,550,0)
 ;;=ERCP^2^49
 ;;^UTILITY(U,$J,358.4,551,0)
 ;;=G-TUBE^6^49
 ;;^UTILITY(U,$J,358.4,552,0)
 ;;=MISCELLANEOUS-PROCEDURES^9^49
 ;;^UTILITY(U,$J,358.4,553,0)
 ;;=IMMUNIZATIONS/INJECTIONS^7^49
 ;;^UTILITY(U,$J,358.4,554,0)
 ;;=ESOPHAGEAL MANOMETRY^3^49
 ;;^UTILITY(U,$J,358.4,555,0)
 ;;=FECAL PREP^5^49
 ;;^UTILITY(U,$J,358.4,556,0)
 ;;=IMMUNOASSAYS^8^49
 ;;^UTILITY(U,$J,358.4,557,0)
 ;;=TRANSEOPHAGEAL ECHOCARDIOGRAPHY^12^49
 ;;^UTILITY(U,$J,358.4,558,0)
 ;;=ESOPHAGUS^1^50
 ;;^UTILITY(U,$J,358.4,559,0)
 ;;=COLON^2^50
